Speaker Profile

M.B.A, CEO, Mission Bio

Charlie Silver is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.


Scalable Single-Cell DNA Analysis for Precision Medicine
With NGS costs dropping, large-scale, single-cell heterogeneity studies now offer great promise to move precision medicine forward in complex diseases characterized by clonally diverse cell populations. Scalable and highly sensitive single-cell DNA analysis enables insights missed by conventional bulk sequencing to impact patient stratification, therapy selection, and disease monitoring.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).